Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Waynac-SP
- Development stage
- Unknown
- Lead developer
- SBM Enterprises
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Waynac-SP is a fixed-dose combination analgesic and anti-inflammatory medication developed and marketed by SBM Enterprises (SBM Pharmaceuticals) in India. It contains three active ingredients: diclofenac (50mg), paracetamol (325mg), and serratiopeptidase (10mg). Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that reduces pain and inflammation by inhibiting cyclooxygenase enzymes. Paracetamol serves as an analgesic and antipyretic. Serratiopeptidase is a proteolytic enzyme that helps reduce swelling and inflammation by breaking down abnormal proteins at the site of injury and promoting healing. This combination is used to manage pain and inflammation associated with conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, muscle aches, and postoperative recovery.
- Brand names
- Waynac-SP
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on Waynac-SP.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Waynac-SP.